Derryl Roderick
Tuesday, 28 July 2015
Praluent Looks Cheap to Those With Extreme Cholesterol
About a million Americans have an inherited condition that defies cholesterol-lowering statins. Even at $14,600 a year, a new drug provides hope.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment